After diagnosis with endometrial cancer, Black women were 8 percent less likely and Hispanic women 10 percent less likely than White women to receive recommended treatment for their cancer, according to a study of some 89,000 U.S. women between 2004 and 2014. Overall in the study, women who did not receive the treatment were 12 percent more likely to die during that time period.
Detailed treatment recommendations, based on extensive results from clinical trials and observation, are prepared by the National Comprehensive Cancer Network, a not-for-profit alliance of 30 leading cancer centers.
See the abstract of the scientific paper “Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment” by Mara Kaspers et al.
